Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma

Systemic therapy for metastatic renal cell carcinoma has continuously evolved over the last two decades. Significant improvements in overall survival and quality of life of patients with advanced disease have been observed. With the approval of combination therapies with PD(L)-1 immune checkpoint in...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimm, Marc-Oliver, Leucht, Katharina, Foller, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618488/
https://www.ncbi.nlm.nih.gov/pubmed/34830621
http://dx.doi.org/10.3390/jcm10225339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618488/
https://www.ncbi.nlm.nih.gov/pubmed/34830621
http://dx.doi.org/10.3390/jcm10225339

Ejemplares similares